Carregant...
Medicare Coverage for Erythropoiesis-Stimulating Agents: The Perfect Storm
Medicare policy changes have an immediate impact on health plans with regard to setting payment policy for providers. So when Medicare tightened payment guidelines for a lucrative class of anemia drugs—erythropoiesis-stimulating agents—an ambitious set of rules was put into effect. Health plans ofte...
Guardat en:
| Format: | Artigo |
|---|---|
| Idioma: | Inglês |
| Publicat: |
Engage Healthcare Communications, LLC
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4106631/ https://ncbi.nlm.nih.gov/pubmed/25126232 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|